 proton-pump inhibit acid-rel diseas omeprazol lansoprazol forerunn group substitut benzimidazol compound gastric proton pump drug potent antisecretori effect final common pathway acid secret prolong potent reduct acid secret signific therapeut advantag antisecretori medic receptor antagonist research experi lansoprazol indic treatment properti acid-rel diseas similar omeprazol omeprazol treatment reflux esophag zollinger-ellison syndrom unit past year approv first-lin therapi duoden ulcer diseas research individu surveil studi safeti studi man anim omeprazol incid spectrum advers event clinic trial similar